Charles Bruce Green's Insider Trades & SAST Disclosures
Charles Bruce Green's most recent trade in Humacyte Inc was a trade of 1,200 Common Stock done at an average price of $4.1 . Disclosure was reported to the exchange on Sept. 13, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Charles Bruce Green.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Humacyte Inc | Charles Bruce Green | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.09 per share. | 13 Sep 2024 | 1,200 | 2,400 | - | 4.1 | 4,908 | Common Stock |
| Humacyte Inc | Charles Bruce Green | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2024 | 1,200 | 10,600 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Charles Bruce Green | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 50,000 | 50,000 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Charles Bruce Green | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 600 | 11,800 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Charles Bruce Green | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.09 per share. | 20 May 2024 | 600 | 1,200 | - | 4.1 | 2,454 | Common Stock |
| Humacyte Inc | Charles Bruce Green | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.09 per share. | 17 May 2024 | 600 | 600 | - | 4.1 | 2,454 | Common Stock |
| Humacyte Inc | Charles Bruce Green | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 600 | 12,400 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Charles Bruce Green | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 8,500 | 8,500 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Charles Bruce Green | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 13,000 | 13,000 | - | - | Stock Options (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges